Journal of Clinical and Translational Hepatology

Papers
(The TQCC of Journal of Clinical and Translational Hepatology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver69
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD39
Statin-induced Liver Injury Patterns: A Clinical Review30
Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study30
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy22
Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review22
Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak22
Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome21
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications20
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma19
Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis17
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)17
Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease17
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail17
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update16
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease16
Guidelines for Prevention and Treatment of Chronic Hepatitis B15
Cytokine Storm of COVID-19 and its Impact on Patients with and without Chronic Liver Disease15
Guidelines for the Management of Cholestatic Liver Diseases (2021)13
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review13
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges13
Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice12
A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates12
Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma12
COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence12
Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)11
Re-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists11
Infections in Alcoholic Hepatitis10
Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts10
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally10
Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment10
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update10
Update on Sphincter of Oddi Dysfunction: A Review10
Hepatotoxicity Induced by Biological Agents: Clinical Features and Current Controversies9
Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway9
Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver9
Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease9
Racial and Health Disparities among Cirrhosis-related Hospitalizations in the USA9
Transplantation of Mesenchymal Stem Cells Attenuates Acute Liver Failure in Mice via an Interleukin-4-dependent Switch to the M2 Macrophage Anti-inflammatory Phenotype9
Selective Androgen Receptor Modulators: An Emerging Liver Toxin9
Coronavirus Disease 2019 and Liver Injury: A Retrospective Analysis of Hospitalized Patients in New York City9
Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome9
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies9
Hepatic Ischemia-reperfusion Injury in Mice was Alleviated by Rac1 Inhibition – More Than Just ROS-inhibition9
Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment9
Identification and Analysis of Gut Microbiota and Functional Metabolism in Decompensated Cirrhosis with Infection8
Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science8
Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases8
Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review8
Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease8
Prognostic Nomogram for Patients with Hepatitis E Virus-related Acute Liver Failure: A Multicenter Study in China8
Subsequent Treatment after Transarterial Chemoembolization Failure/Refractoriness: A Review Based on Published Evidence8
Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice8
Characteristics and Outcome of Exertional Heatstroke Patients Complicated by Acute Hepatic Injury: A Cohort Study8
Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation8
A Nomogram-based Model to Predict Neoplastic Risk for Patients with Gallbladder Polyps8
Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease8
Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis8
Gut Microbiota Dysbiosis Strengthens Kupffer Cell-mediated Hepatitis B Virus Persistence through Inducing Endotoxemia in Mice8
Development and Validation of a Nomogram Based on Perioperative Factors to Predict Post-hepatectomy Liver Failure7
Severe Acute Hepatitis of Unknown Origin in Children: What Do We Know Today?7
A K-nearest Neighbor Model to Predict Early Recurrence of Hepatocellular Carcinoma After Resection7
Liver Function Derangement in Patients with Severe Fever and Thrombocytopenia Syndrome7
Development and Validation of a Nomogram for 90-day Outcome in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure7
Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research7
Detection of Prognostic Biomarkers for Hepatocellular Carcinoma through CircRNA-associated CeRNA Analysis7
HBeAg-negative Patients with Chronic Hepatitis B Virus Infection and Normal Alanine Aminotransferase: Wait or Treat?7
Associating Preoperative MRI Features and Gene Expression Signatures of Early-stage Hepatocellular Carcinoma Patients using Machine Learning7
KRT17 Promotes the Activation of HSCs via EMT in Liver Fibrosis7
Pediatric Acute Severe Hepatitis of Unknown Origin: What is New?7
Sarcopenia in Chronic Liver Disease: A Metabolic Perspective7
Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling7
Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma7
Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China7
Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis7
Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis7
Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions6
Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study6
A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma6
MAFLD Not NAFLD is Associated with Impairment of Health-related Quality of Life6
Breath Biopsy® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection6
The Gut Microbiome and Ferroptosis in MAFLD6
HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site6
Expression and Regulatory Network Analysis of Function of Small Nucleolar RNA Host Gene 4 in Hepatocellular Carcinoma6
Targeted Mitochondrial Delivery to Hepatocytes: A Review6
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China6
Hepatic Arterioportal Fistulas: A Retrospective Analysis of 97 Cases6
Current Status and Analysis of Machine Learning in Hepatocellular Carcinoma6
CircTUBD1 Regulates Radiation-induced Liver Fibrosis Response via a circTUBD1/micro-203a-3p/Smad3 Positive Feedback Loop6
Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase6
Extracellular Polysaccharide from Rhizopus nigricans Inhibits Hepatocellular Carcinoma via miR-494-3p/TRIM36 Axis and Cyclin E Ubiquitination6
Hepatic Histoplasmosis: An Update6
Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization5
Coronavirus Disease-2019 (COVID-19) and the Liver5
Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease5
B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection5
Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases5
Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota5
Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 20195
An Ideal Hallmark Closest to Complete Cure of Chronic Hepatitis B Patients: High-sensitivity Quantitative HBsAg Loss5
Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis5
Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma5
Regulatory Effect of JAK2/STAT3 on the Immune Function of Endotoxin-tolerant Dendritic Cells and its Involvement in Acute Liver Failure5
Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease5
Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment5
High Frame Rate Contrast-enhanced Ultrasound Helps Differentiate Malignant and Benign Focal Liver Lesions5
Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center5
Diagnostic Accuracy of the Apparent Diffusion Coefficient for Microvascular Invasion in Hepatocellular Carcinoma: A Meta-analysis5
Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease5
Noncanonical NF-κB Signaling Pathway in Liver Diseases5
Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China5
Single-center Experience in the Diagnosis and Treatment of Hepatic Perivascular Epithelioid Cell Neoplasm5
Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic5
Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)5
Added Value of Quantitative Apparent Diffusion Coefficients for Identifying Small Hepatocellular Carcinoma from Benign Nodule Categorized as LI-RADS 3 and 4 in Cirrhosis4
2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus4
Alcohol and Metabolic-associated Fatty Liver Disease4
Effects of Low-dose and High-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy4
Establishment of a Rat Model of Liver Venous Deprivation: Simultaneous Portal and Hepatic Vein Ligation4
Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease4
Diagnostic and Prognostic Value of Protein Post-Translational Modifications in Hepatocellular Carcinoma4
SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites4
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis4
Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma4
Impact of Helicobacter pylori Infection on the Pathogenesis and Management of Nonalcoholic Fatty Liver Disease4
Functional Cure of Chronic Hepatitis B with Antiviral Treatment in Children having High-level Viremia and Normal or Mildly Elevated Serum Aminotransferase4
Roles of SET7/9 and LSD1 in the Pathogenesis of Arsenic-induced Hepatocyte Apoptosis4
Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma4
A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis4
Nonalcoholic Fatty Liver Disease after Liver Transplant4
Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms4
Seronegative Autoimmune Hepatitis4
Prospect of Animal Models for Acute-on-chronic Liver Failure: A Mini-review4
Dermcidin Enhances the Migration, Invasion, and Metastasis of Hepatocellular Carcinoma Cells In Vitro and In Vivo4
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma4
Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis4
Osteopontin Promotes Macrophage M1 Polarization by Activation of the JAK1/STAT1/HMGB1 Signaling Pathway in Nonalcoholic Fatty Liver Disease4
Sex-specific Cutoff Values of Visceral Fat Area for Lean vs. Overweight/Obese Nonalcoholic Fatty Liver Disease in Asians4
Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores4
HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters4
Therapeutic Value of Estrogen Receptor α in Hepatocellular Carcinoma Based on Molecular Mechanisms4
Premorbid Steatohepatitis Increases the Seriousness of Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice4
Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis4
Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING Pathway4
UMSCs Attenuate LPS/D-GalN-Induced Acute Liver Failure in Mice by Down-regulating the MyD88/NF-κB Pathway4
Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver4
Hepatocellular Carcinoma: Downstaging to Liver Transplantation as Curative Therapy4
0.052130937576294